Shigenori Furukawa
Fukushima Medical University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shigenori Furukawa.
Oncology Letters | 2014
Takafumi Watanabe; Masahiko Shibata; Hiroshi Nishiyama; Shu Soeda; Shigenori Furukawa; Kenji Gonda; Seiichi Takenoshita; Keiya Fujimori
Poor nutritional status is common in ovarian cancer. It is well known that the nutritional status of a patient with malignant disease is associated with survival, and that it can be assessed by serum levels of rapid turnover proteins (RTPs), such as retinol binding protein, prealbumin and transferrin. Systemic inflammation, usually observed in the form of elevated C-reactive protein (CRP) or neutrophil/lymphocyte ratio (NLR), occurs by various mechanisms involving numerous pro-inflammatory cytokines. These include interleukin (IL)-17 and other soluble protein mediators, such as soluble IL-2 receptor (sIL-2R) and vascular endothelial growth factor (VEGF). In this study, circulating levels of RTP were decreased in advanced stages of ovarian cancer, and significant inverse correlations were found between RTP levels and serum levels of CRP or NLR. CRP levels were also correlated with serum levels of VEGF and sIL-2R. Moreover, NLR, VEGF and sIL-2R levels, and IL-17 production, were all inversely correlated with RTP levels. These findings indicate that chronic inflammation may be associated with compromised immune function, such as an impaired T-cell response, via various inflammatory proteins, including sIL-2R, VEGF and IL-17. The key mechanisms leading to cancer cachexia, in which nutritional impairment is a major clinical issue, appear to be primarily immune reactions caused by chronic inflammation. Anti-inflammatory treatments may be effective in clinically improving various symptoms associated with these mechanisms.
Journal of Obstetrics and Gynaecology Research | 2013
Satoshi Suzuki; Shigenori Furukawa; Hyo Kyozuka; Takafumi Watanabe; Hidenori Takahashi; Keiya Fujimori
Paraovarian tumor of borderline malignancy is rare. Only 13 cases in Japan, including the present cases, and 40 cases overseas have been reported. We report two cases of paraovarian tumor of borderline malignancy. Case 1: A 38‐year‐old woman was found to have a right ovarian cyst. Transvaginal ultrasonography showed a unilocular cystic tumor and a solid part of 8 mm in diameter within the tumor. Malignancy could not be ruled out, therefore the laparotomy was performed. The tumor was paraovarian tumor. Intraoperative rapid histological diagnosis was made and the patient was diagnosed with a serous borderline tumor. There has been no recurrence 1 year after surgery. Case 2: A 30‐year‐old woman was found to have a right hydrosalpinx, or an ovarian cyst, with a solid part inside. Transvaginal ultrasonography showed the solid part within the tumor was 14 × 9 mm. Laparoscopic surgery was performed and we diagnosed the tumor as paraovarian cyst. Histological diagnosis was mucinous borderline tumor. There has been no recurrence 11 months after surgery.
International Journal of Surgery Case Reports | 2015
Shigenori Furukawa; Kiyoshi Kanno; Manabu Kojima; Miki Ohara; Shu Soeda; Satoshi Suzuki; Takafumi Watanabe; Hiroshi Nishiyama; Tsuyoshi Honda; Keiya Fujimori
Highlights • Sclerosing stromal tumor (SST) is an extremely rare benign tumor of the ovary and preoperative diagnosis of SST is difficult as it often mimics a malignant tumor.• SST occurs in young women.• Many cases of SST were treated by abdominal oophorectomy and laparoscopic surgery is seldom performed in SST cases.• We report a case of SST of the ovary in an 18-year-old girl who was diagnosed by preoperative imaging and underwent laparoscopic cystectomy.
Anticancer Research | 2013
Shigenori Furukawa; Shu Soeda; Yuichiro Kiko; Osamu Suzuki; Yuko Hashimoto; Takafumi Watanabe; Hiroshi Nishiyama; Kazuhiro Tasaki; Hiroshi Hojo; Masafumi Abe; Keiya Fujimori
SpringerPlus | 2014
Shigenori Furukawa; Shu Soeda; Takafumi Watanabe; Hiroshi Nishiyama; Keiya Fujimori
Biomedical Reports | 2013
Takafumi Watanabe; Masahiko Shibata; Hiroshi Nishiyama; Shu Soeda; Shigenori Furukawa; Kenji Gonda; Seiichi Takenoshita; Keiya Fujimori
Tohoku Journal of Experimental Medicine | 2012
Shu Soeda; Junko Ushijima; Shigenori Furukawa; Masayuki Miyajima; Kotaro Sakuma; Takafumi Watanabe; Makoto Miyazaki; Yuko Hashimoto; Hiroshi Nishiyama; Keiya Fujimori
The Journal of the Japanese Society of Clinical Cytology | 2012
Yutaka Morimura; Seiko Chiba; Yukari Araki; Yoshinori Soeta; Takashi Tsukahara; Shinichi Shibata; Shigenori Furukawa; Shu Soeda; Hiroshi Nishiyama; Keiya Fujimori
日本産科婦人科學會雜誌 | 2016
Shu Soeda; Manabu Kojima; Shinji Nomura; Shigenori Furukawa; Hiroshi Nishiyama; Takafumi Watanabe; Hidekazu Yamada; Keiya Fujimori
Fukushima journal of medical science | 2014
Satoshi Suzuki; Shigenori Furukawa; Miki Ohara; Kiyoshi Kanno; Shun Yasuda; Takeharu Ohzeki; Takafumi Watanabe; Hidenori Takahashi; Hiroshi Suzuki; Keiya Fujimori